Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'

被引：0
|
作者：
Vivaldi, Caterina [1 ]
Fornaro, Lorenzo [1 ]
Caparello, Chiara [1 ]
Falcone, Alfredo [1 ]
Vasile, Enrico [1 ]
机构：
[1] Azienda Osped Univ Pisana, Polo Oncol, Via Roma 67, I-56126 Pisa, Italy
来源：
BRITISH JOURNAL OF CANCER | 2016年 / 114卷 / 11期
关键词：
CANCER;
D O I：
10.1038/bjc.2016.69
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：e8 / e8
页数：1
相关论文
共 50 条
  • [21] Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
    Chen, Shuling
    Li, Jiaxin
    Dong, Aoran
    Liu, Zelong
    Zhu, Meiyan
    Jin, Meng
    Wei, Guangyan
    Wu, Shuang
    Wang, Yan
    Chen, Yong
    Peng, Zhenwei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [22] Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by folfirinox in metastatic pancreatic adenocarcinoma
    Assenat, E.
    de la Fouchardiere, C.
    Mollevi, C.
    Samalin, E.
    Portales, F.
    Desseigne, F.
    Carenco, C.
    Dupuy, M.
    Lopez-Martinez, E.
    Fiess, C.
    Mazard, T.
    Ychou, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] FOLFIRINOX for advanced pancreatic cancer patients after nab-paclitaxel plus gemcitabine failure: retrospective analysis
    Matsumoto, Toshihiko
    Kimura, Shogo
    Himei, Hitomi
    Okazaki, Ukyo
    Kurioka, Yusuke
    Tsuduki, Takao
    Takagi, Shijiro
    Takatani, Masahiro
    Hiramatsu, Ysushi
    Morishita, Hirofumi
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: Report of an effective new strategy
    Portal, Alix
    Pernot, Simon
    Siauve, Nathalie
    Landi, Bruno
    Lepere, Celine
    Colussi, Orianne
    Rougier, Philippe
    Zaanan, Aziz
    Verriere, Benjamin
    Taieb, Julien
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2014, 38 (02) : E23 - E26
  • [25] Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in metastatic pancreatic adenocarcinoma.
    Assenat, Eric
    De La Fouchardiere, Christelle
    Mollevi, Caroline
    Samalin, Emmanuelle
    Portales, Fabienne
    Desseigne, Francoise
    Carenco, Christophe
    Dupuy, Marie
    Lopez-Martinez, Ernesto
    Fiess, Catherine
    Mazard, Thibault
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Survival outcomes based on sequence of therapy using FOLFIRINOX and nab-paclitaxel plus gemcitabine in metastatic pancreatic ductal adenocarcinoma
    Baron, Kelsey
    Nevala-Plagemann, Christopher Duane
    Moser, Justin
    Haaland, Benjamin
    Wang, Xuechen
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.
    Assenat, Eric
    De La Fouchardiere, Christelle
    Mollevi, Caroline
    Samalin, Emmanuelle
    Portales, Fabienne
    Desseigne, Francoise
    Carenco, Christophe
    Dupuy, Marie
    Lopez-Martinez, Ernesto
    Fiess, Catherine
    Mazard, Thibault
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma
    Klein-Brill, Avital
    Amar-Farkash, Shlomit
    Lawrence, Gabriella
    Collisson, Eric A.
    Aran, Dvir
    JAMA NETWORK OPEN, 2022, 5 (06) : E2216199
  • [29] Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel plus Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma
    Baron, Margaret Kelsey
    Wang, Xuechen
    Nevala-Plagemann, Christopher
    Moser, Justin C.
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    PANCREAS, 2021, 50 (06) : 796 - 802
  • [30] FOLFIRINOX versus gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer: a single-center cohort study
    Cho, I.
    Kang, H.
    Jo, J.
    Lee, H.
    Chung, M.
    Park, J.
    Park, S.
    Song, S.
    Park, M.
    An, C.
    Jung, S.
    Bang, S.
    ANNALS OF ONCOLOGY, 2018, 29
12345